EE04498B1 - Erütromütsiini derivaadid, nende valmistamismeetod ja neid sisaldav farmatseutiline kompositsioon - Google Patents

Erütromütsiini derivaadid, nende valmistamismeetod ja neid sisaldav farmatseutiline kompositsioon

Info

Publication number
EE04498B1
EE04498B1 EE9500080A EE9500080A EE04498B1 EE 04498 B1 EE04498 B1 EE 04498B1 EE 9500080 A EE9500080 A EE 9500080A EE 9500080 A EE9500080 A EE 9500080A EE 04498 B1 EE04498 B1 EE 04498B1
Authority
EE
Estonia
Prior art keywords
preparation
pharmaceutical composition
composition containing
erythromycin derivatives
erythromycin
Prior art date
Application number
EE9500080A
Other languages
English (en)
Estonian (et)
Other versions
EE9500080A (et
Inventor
Agouridas Constantin
Benedetti Yannick
Chantot Jean-Fran�Ois
Denis Alexis
Le Martret Odile
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of EE9500080A publication Critical patent/EE9500080A/xx
Publication of EE04498B1 publication Critical patent/EE04498B1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EE9500080A 1994-04-08 1995-04-06 Erütromütsiini derivaadid, nende valmistamismeetod ja neid sisaldav farmatseutiline kompositsioon EE04498B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9404154A FR2718450B1 (fr) 1994-04-08 1994-04-08 Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
PCT/FR1995/000441 WO1995027720A1 (fr) 1994-04-08 1995-04-06 Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Publications (2)

Publication Number Publication Date
EE9500080A EE9500080A (et) 1996-12-16
EE04498B1 true EE04498B1 (et) 2005-06-15

Family

ID=9461886

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9500080A EE04498B1 (et) 1994-04-08 1995-04-06 Erütromütsiini derivaadid, nende valmistamismeetod ja neid sisaldav farmatseutiline kompositsioon

Country Status (49)

Country Link
US (2) US5656607A (cg-RX-API-DMAC7.html)
EP (1) EP0676409B1 (cg-RX-API-DMAC7.html)
JP (1) JP3000023B2 (cg-RX-API-DMAC7.html)
KR (1) KR100317148B1 (cg-RX-API-DMAC7.html)
CN (1) CN1059445C (cg-RX-API-DMAC7.html)
AP (1) AP587A (cg-RX-API-DMAC7.html)
AT (1) ATE234853T1 (cg-RX-API-DMAC7.html)
AU (1) AU684939B2 (cg-RX-API-DMAC7.html)
BG (1) BG61916B1 (cg-RX-API-DMAC7.html)
BR (1) BR9506147A (cg-RX-API-DMAC7.html)
CA (1) CA2164638C (cg-RX-API-DMAC7.html)
CO (1) CO4370097A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ296005B6 (cg-RX-API-DMAC7.html)
DE (1) DE69529934T2 (cg-RX-API-DMAC7.html)
DK (1) DK0676409T3 (cg-RX-API-DMAC7.html)
DZ (1) DZ1869A1 (cg-RX-API-DMAC7.html)
EE (1) EE04498B1 (cg-RX-API-DMAC7.html)
ES (1) ES2189820T3 (cg-RX-API-DMAC7.html)
FI (1) FI111264B (cg-RX-API-DMAC7.html)
FR (1) FR2718450B1 (cg-RX-API-DMAC7.html)
GB (1) GB2288174A (cg-RX-API-DMAC7.html)
GE (1) GEP19991836B (cg-RX-API-DMAC7.html)
HR (1) HRP950217B1 (cg-RX-API-DMAC7.html)
HU (1) HU215396B (cg-RX-API-DMAC7.html)
IL (1) IL112954A (cg-RX-API-DMAC7.html)
IS (1) IS1865B (cg-RX-API-DMAC7.html)
JO (1) JO1850B1 (cg-RX-API-DMAC7.html)
LV (1) LV11182B (cg-RX-API-DMAC7.html)
MA (1) MA23501A1 (cg-RX-API-DMAC7.html)
MD (1) MD663G2 (cg-RX-API-DMAC7.html)
MY (1) MY114672A (cg-RX-API-DMAC7.html)
NO (1) NO308361B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ284498A (cg-RX-API-DMAC7.html)
OA (1) OA10200A (cg-RX-API-DMAC7.html)
PE (1) PE2896A1 (cg-RX-API-DMAC7.html)
PL (1) PL180837B1 (cg-RX-API-DMAC7.html)
PT (1) PT676409E (cg-RX-API-DMAC7.html)
RO (1) RO115634B1 (cg-RX-API-DMAC7.html)
RU (1) RU2141965C1 (cg-RX-API-DMAC7.html)
SA (1) SA97170757A (cg-RX-API-DMAC7.html)
SI (1) SI0676409T1 (cg-RX-API-DMAC7.html)
SK (1) SK284079B6 (cg-RX-API-DMAC7.html)
SV (1) SV1995000018A (cg-RX-API-DMAC7.html)
TN (1) TNSN95026A1 (cg-RX-API-DMAC7.html)
TW (1) TW316908B (cg-RX-API-DMAC7.html)
UA (1) UA44705C2 (cg-RX-API-DMAC7.html)
WO (1) WO1995027720A1 (cg-RX-API-DMAC7.html)
YU (1) YU49221B (cg-RX-API-DMAC7.html)
ZA (1) ZA952059B (cg-RX-API-DMAC7.html)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2732023B1 (fr) * 1995-03-22 1997-04-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2745289B1 (fr) * 1996-02-28 1998-05-29 Roussel Uclaf Nouveaux derives de l'acide 1(2h) quinoleine carboxylique, leur procede de preparation et leur application a la synthese de produits doues de proprietes antibiotiques
US5750510A (en) * 1997-04-04 1998-05-12 Abbott Laboratories 3-descladinose-2,3-anhydroerythromycin derivatives
DE69723848T2 (de) * 1996-05-07 2004-07-01 Abbott Laboratories, Abbott Park 3-descladinose-2,3-anhydroerythromycin-derivate
FR2748746B1 (fr) * 1996-05-14 1998-08-14 Hoechst Marion Roussel Inc Nouveau procede d'isomerisation du radical methyle en 10 de derives de l'erythromycine
FR2751656B1 (fr) * 1996-07-24 1998-10-16 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
IL128681A0 (en) * 1996-09-04 2000-01-31 Abbott Lab 6-O substituted ketolides having antibacterial activity
UA51730C2 (uk) * 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
FR2757168B1 (fr) * 1996-12-12 1999-06-11 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2760017B1 (fr) * 1997-02-27 1999-04-30 Hoechst Marion Roussel Inc Nouveaux derives de l'erytromycine, leur procede de preparation et leur application comme medicaments
WO1998040392A1 (fr) * 1997-03-10 1998-09-17 Taisho Pharmaceutical Co., Ltd. Derives d'erythromycine a
AU6421398A (en) * 1997-03-24 1998-10-20 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
AU6932098A (en) * 1997-05-09 1998-12-08 Pfizer Products Inc. Erythromycin derivatives
US5922683A (en) * 1997-05-29 1999-07-13 Abbott Laboratories Multicyclic erythromycin derivatives
EP0988308A1 (en) * 1997-06-11 2000-03-29 Pfizer Products Inc. 9-oxime erythromycin derivatives
FR2771008B1 (fr) * 1997-11-17 2000-04-28 Hoechst Marion Roussel Inc Utilisation des ketolides pour la preparation de compositions pharmaceutiques destinees a prevenir les complications thrombotiques arterielles liees a l'atherosclerose
AP1060A (en) * 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
HRP980189B1 (en) * 1998-04-06 2004-04-30 Pliva Pharm & Chem Works Novel 15-membered lactams ketolides
EP1115732B1 (en) 1998-09-22 2005-06-29 Pfizer Products Inc. Carbamate and carbazate ketolide antibiotics
FR2786188B1 (fr) * 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments
EP1749832A3 (en) * 1998-12-10 2008-03-26 Pfizer Products Incorporated Carbamate and carbazate ketolide antibiotics
ATE344269T1 (de) 1998-12-10 2006-11-15 Pfizer Prod Inc Carbamat und carbazat ketolid antibiotika
EP1298138B1 (en) * 1998-12-10 2006-11-02 Pfizer Products Inc. Carbamate and Carbazate Ketolide Antibiotics
FR2789392B1 (fr) 1999-02-04 2001-10-05 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
US6054435A (en) * 1999-03-19 2000-04-25 Abbott Laboratories 6-O-substituted macrolides having antibacterial activity
AU773678B2 (en) * 1999-04-16 2004-06-03 Kosan Biosciences, Inc. Macrolide antiinfective agents
AU4354900A (en) 1999-04-16 2000-11-02 Kosan Biosciences, Inc. Ketolide antibacterials
US6590083B1 (en) 1999-04-16 2003-07-08 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
OA11945A (en) * 1999-05-24 2006-04-13 Pfizer Prod Inc 13-Methyl erythromycin derivatives.
EP1404693A2 (en) * 2001-07-03 2004-04-07 Chiron Corporation C12 modified erythromycin macrolides and ketolides having antibacterial activity
CN105039464A (zh) 2002-07-01 2015-11-11 阿基昂生命科学公司,以生物技术资源部的名义经营 用于生产葡糖胺和n-乙酰氨基葡糖的方法和物质
WO2004080391A2 (en) 2003-03-10 2004-09-23 Optimer Pharmaceuticals, Inc. Novel antibacterial agents
WO2004096822A2 (en) * 2003-04-25 2004-11-11 Chiron Corporation Pyridyl substituted ketolide antibiotics
WO2004096823A2 (en) * 2003-04-25 2004-11-11 Chiron Corporation Novel ketolide derivatives
JP5698979B2 (ja) 2007-10-25 2015-04-08 センプラ ファーマシューティカルズ,インコーポレイテッド マクロライド系抗菌剤の調製プロセス
HRP20160222T1 (hr) * 2008-10-24 2016-04-08 Cempra Pharmaceuticals, Inc. Biozaštite uporabom makrolida koji sadrže triazol
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
WO2011032052A1 (en) 2009-09-10 2011-03-17 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and mac diseases
KR102006200B1 (ko) 2010-03-22 2019-08-01 셈프라 파마슈티컬스, 인크. 매크로라이드의 결정 형태들 및 그 용도들
EP2571506B1 (en) 2010-05-20 2017-05-10 Cempra Pharmaceuticals, Inc. Processes for preparing macrolides and ketolides and intermediates therefor
KR20130120458A (ko) 2010-09-10 2013-11-04 셈프라 파마슈티컬스, 인크. 질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드
WO2013148891A1 (en) 2012-03-27 2013-10-03 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
EP2968801B1 (en) 2013-03-14 2018-09-26 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
CN105188712A (zh) 2013-03-15 2015-12-23 森普拉制药公司 用于制备大环内酯抗菌剂的收敛方法
AU2014248014B2 (en) 2013-04-04 2018-11-08 President And Fellows Of Harvard College Macrolides and methods of their preparation and use
JP2017531663A (ja) 2014-10-08 2017-10-26 プレジデント アンド フェローズ オブ ハーバード カレッジ 14員ケトライドならびにそれらの調製および使用の方法
EP3273969A4 (en) 2015-03-25 2018-11-21 President and Fellows of Harvard College Macrolides with modified desosamine sugars and uses thereof
MD1222Z (ro) * 2017-05-31 2018-08-31 ИНСТИТУТ ЭЛЕКТРОННОЙ ИНЖЕНЕРИИ И НАНОТЕХНОЛОГИЙ "D. Ghitu" АНМ Procedeu de tratare a materialului săditor al florilor înainte de plantare
JP7199722B2 (ja) 2019-12-25 2023-01-06 旭精工株式会社 硬貨搬送振分機構及びそれを備えた硬貨識別搬送装置

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3868414A (en) * 1973-01-22 1975-02-25 Merck & Co Inc Tetrahydrofluorene carboxylic acids and related compounds
AT342770B (de) * 1975-04-07 1978-04-25 Thomae Gmbh Dr K Verfahren zur herstellung neuer erythromycinderivate
DE2842759A1 (de) * 1978-09-30 1980-04-10 Merck Patent Gmbh Basische aether, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
FR2692579B1 (fr) * 1992-06-19 1995-06-02 Roussel Uclaf Nouveaux dérivés de la picromycine, leur procédé de préparation et leur application comme médicaments.
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2697524B1 (fr) * 1992-11-05 1994-12-23 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
HRP930014A2 (en) * 1993-01-08 1994-08-31 Pliva Pharm & Chem Works 9-deoxo-9a-aza-11-deoxy-9a-homoeritromycin a 9a, 11-cyclic carbamates
FR2702480B1 (fr) * 1993-03-09 1995-04-28 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Also Published As

Publication number Publication date
AU684939B2 (en) 1998-01-08
IL112954A0 (en) 1995-06-29
SV1995000018A (es) 1997-10-24
TW316908B (cg-RX-API-DMAC7.html) 1997-10-01
MD663F1 (ro) 1997-01-31
MD663G2 (ro) 1997-07-31
BG61916B1 (bg) 1998-09-30
NO954942L (no) 1996-02-07
YU49221B (sh) 2004-11-25
RO115634B1 (ro) 2000-04-28
DZ1869A1 (fr) 2002-02-17
KR100317148B1 (ko) 2002-06-22
EE9500080A (et) 1996-12-16
HRP950217A2 (en) 1997-08-31
SK154695A3 (en) 1996-10-02
US5656607A (en) 1997-08-12
AU2310795A (en) 1995-10-30
CN1126997A (zh) 1996-07-17
AP9500743A0 (en) 1995-07-31
DK0676409T3 (da) 2003-06-23
YU21695A (sh) 1997-12-05
LV11182B (en) 1997-04-20
PE2896A1 (es) 1996-02-12
PL180837B1 (pl) 2001-04-30
DE69529934T2 (de) 2003-09-04
PT676409E (pt) 2003-08-29
FR2718450A1 (fr) 1995-10-13
IS4309A (is) 1995-11-17
CA2164638C (fr) 2003-12-30
IL112954A (en) 2000-07-16
GB2288174A (en) 1995-10-11
CZ322395A3 (en) 1996-08-14
IS1865B (is) 2003-05-02
NO308361B1 (no) 2000-09-04
DE69529934D1 (de) 2003-04-24
HU215396B (hu) 1998-12-28
JP3000023B2 (ja) 2000-01-17
CO4370097A1 (es) 1996-10-07
ES2189820T3 (es) 2003-07-16
LV11182A (lv) 1996-04-20
GB9506856D0 (en) 1995-05-24
SI0676409T1 (en) 2003-06-30
HU9503505D0 (en) 1996-02-28
SK284079B6 (sk) 2004-09-08
NZ284498A (en) 1997-07-27
UA44705C2 (uk) 2002-03-15
ZA952059B (en) 1996-03-13
FI955913A7 (fi) 1995-12-08
RU2141965C1 (ru) 1999-11-27
CA2164638A1 (fr) 1995-10-19
AP587A (en) 1997-04-29
BR9506147A (pt) 1996-04-16
OA10200A (fr) 1996-12-18
GEP19991836B (en) 1999-11-05
HRP950217B1 (en) 2004-06-30
FR2718450B1 (fr) 1997-01-10
NO954942D0 (no) 1995-12-06
MY114672A (en) 2002-12-31
MA23501A1 (fr) 1995-12-31
PL311871A1 (en) 1996-03-18
US5760233A (en) 1998-06-02
ATE234853T1 (de) 2003-04-15
HUT73772A (en) 1996-09-30
BG100150A (bg) 1996-06-28
CZ296005B6 (cs) 2005-12-14
FI111264B (fi) 2003-06-30
CN1059445C (zh) 2000-12-13
TNSN95026A1 (fr) 1996-02-06
WO1995027720A1 (fr) 1995-10-19
FI955913A0 (fi) 1995-12-08
EP0676409A1 (fr) 1995-10-11
JPH07278177A (ja) 1995-10-24
EP0676409B1 (fr) 2003-03-19
JO1850B1 (en) 1995-12-27
SA97170757A (ar) 2005-12-03

Similar Documents

Publication Publication Date Title
EE04498B1 (et) Erütromütsiini derivaadid, nende valmistamismeetod ja neid sisaldav farmatseutiline kompositsioon
EE03263B1 (et) Erütromütsiini derivaadid, nende valmistamismeetod, farmatseutiline kompositsioon ja vaheühendid
EE200000707A (et) Oksasolidinooni derivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid
EE9700333A (et) Substitueeritud 4-fenüülaminotiasoolid, nende valmistamise meetod ja neid sisaldavad farmakoloogilised kompositsioonid
EE04489B1 (et) Atsüülpseudodipeptiidid, nende valmistamise meetod ja neid sisaldavad farmatseutilised kompositsioonid
HUP0000721A3 (en) Gemcitabine derivatives, process for their preparation and pharmaceutical compositions containing them
EE200000168A (et) Karboksamidotiasoolderivaadid, nende valmistamine ja neid sisaldavad farmatseutilised kompositsioonid
EE9900015A (et) Sünteetilised polüsahhariidid, nende valmistamise meetod ja neid sisaldavad farmatseutilised kompositsioonid
FI954304A7 (fi) Uudet bentsopyraanijohdannaiset, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
FI953898A7 (fi) Glysiiniamidijohdannaisia, menetelmiä niiden valmistamiseksi ja niitä sisältäviä lääkeaineita
EE9800265A (et) Erütromütsiini derivaadid, nende valmistamismeetod ja kasutamine ravimitena
FI952550A7 (fi) Uudet N-pyridyylikarboksamidit ja johdannaiset, menetelmät niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
EE9800426A (et) Asendatud 2,4-tiasolidiindiooni derivaadid, nende valmistamismeetodid ja neid sisaldavad farmatseutilised kompositsioonid
FI943688L (fi) Uudet 11-bentsaldoksiimi-17beta-metoksi-27alfa-metoksi-metyyli-estradieenijohdannaiset, menetelmät niiden valmistamiseksi ja näitä sisältävät lääkeaineet
FI950625A7 (fi) Polysubstituoituja 3-asyyliamino-5-fenyyli-1,4-bentsodiatsepiini-2-onijohdannaisia, menetelmä niiden valmistamiseksi ja niitä sisältäviä farmaseuttisia koostumuksia
FI930974A7 (fi) Substituoidut aminofosonaattijohdannaiset, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
EE03825B1 (et) 2-tsüanoiminoimidasooli derivaadid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
FI956278A0 (fi) Substituoituja 4-fenyylitiatsolijohdannaisia, menetelmä niiden valmistamiseksi ja niitä sisältäviä farmaseuttisia koostumuksia
EE9800069A (et) Bensotiasolooni derivaadid, protsessid ja kasutatud vaheühendid nende saamiseks ning neid sisaldavad ravimkoostised
HUT77126A (hu) Antibiotikus hatású eritromicin A 9-0-oxim -származékok, ezeket tartalmazó gyógyszerkészítmények és eljárás a vegyületek előállítására
EE9800264A (et) Taksoidid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid
FI960316L (fi) Oksatiolaanit, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
FI955085L (fi) Uudet diosmetiiniyhdisteet, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
EE9400148A (et) Tienotiasiini derivaadid, nende valmistamise meetod ja neid sisaldavad farmatseutilised preparaadid
FI941094L (fi) Uudet erytromysiinijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö lääkkeinä

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231